Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and Wegovy develop complications with their eyesight, highlighting that we ...

Whoopi Goldberg has alerted fans of a fake weight loss ad using her likeness on Instagram. Goldberg said the ad used ...

Researchers are studying whether popular weight-loss drugs could reduce cravings not only for food, but for alcohol, heroin and other addictive drugs. Some patients taking the drugs for weight loss ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Too many young people are prescribed pills for mental illness. Are we repeating history with GLP-1s?

EGOT winner Whoopi Goldberg railed against an ad that's circulating on social media with a manipulated version of her ...

Sharon was on hand to promote the event alongside the band's originals guitarist Tony Iommi, after admitting she is ...

The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...

Novo Nordisk has a dominant position in diabetes and weight-loss drugs, strong financial growth outlook, and great potential. Click to read why NVO is a Strong Buy.

The U.S. Food and Drug Administration ordered a hold on a study of an early-stage obesity drug being developed by Amgen, another potential setback in the company’s efforts to join the booming weight ...

Novo’s newest GLP-1, CagriSema, is the first big test of Novo Nordisk’s future as the leader in the obesity treatment market.

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...